Insomnia market was valued at $4.3 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 3.9% from 2021 to 2030, reaching a value of $6.3 billion by 2030

According to a report by Allied Market Research, the global insomnia market was valued at $4.3 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 3.9% from 2021 to 2030, reaching a value of $6.3 billion by 2030. The report also states that the non-pharmacological therapy segment is expected to witness the highest growth during the forecast period. North America is expected to hold the largest share of the market, followed by Europe and Asia-Pacific.

Insomnia is a sleep disorder that affects many people and can have a significant impact on their quality of life. It's important to identify the underlying cause of insomnia in order to develop an effective treatment plan. Some common strategies for treating insomnia include improving sleep hygiene, such as establishing a regular sleep schedule and avoiding caffeine and other stimulants before bedtime, cognitive behavioral therapy, medication, and addressing any underlying health conditions or psychological issues.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/request-sample/2373

The global insomnia market is indeed driven by a variety of factors, including the increase in prevalence of sleep disorders such as insomnia and parasomnias, as well as the rise in mental health conditions such as depression and anxiety, which can cause difficulty sleeping. In addition, the long-term use of certain medications to treat chronic diseases can also affect a patient's sleep quality, further driving the demand for treatments and solutions to address insomnia. The increase in cancer prevalence and the use of chemotherapy, which can cause various side effects including disrupted sleep, is another factor that contributes to the growth of the insomnia market. Overall, the market for insomnia treatments is expected to continue to grow as the prevalence of these underlying conditions and the associated sleep disorders continues to increase globally.

The key players operating in the global insomnia market include, 𝐌𝐢𝐧𝐞𝐫𝐯𝐚 𝐍𝐞𝐮𝐫𝐨𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐈𝐧𝐜., 𝐂𝐮𝐫𝐫𝐚𝐱 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 𝐋𝐋𝐂, 𝐄𝐢𝐬𝐚𝐢, 𝐂𝐨. 𝐋𝐭𝐝., 𝐌𝐞𝐫𝐜𝐤 & 𝐂𝐨. 𝐈𝐧𝐜., 𝐏𝐟𝐢𝐳𝐞𝐫, 𝐈𝐧𝐜., 𝐒𝐚𝐧𝐨𝐟𝐢, 𝐓𝐚𝐤𝐞𝐝𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐋𝐭𝐝., 𝐕𝐚𝐧𝐝𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬, 𝐕𝐢𝐚𝐭𝐫𝐢𝐬 (𝐌𝐲𝐥𝐚𝐧 𝐍𝐕), 𝐚𝐧𝐝 𝐙𝐲𝐝𝐮𝐬 𝐂𝐚𝐝𝐢𝐥𝐚.

The rise in work-related stress, including long work hours and shift work, can certainly contribute to the prevalence of insomnia and the growth of the insomnia treatment market. The increase in insomnia centers and sleep diagnostic centers also provides more opportunities for people to seek out treatment and improve their sleep quality. Additionally, the adoption of non-pharmacological sleep therapy, such as cognitive behavioral therapy, yoga, and hypnotherapy, is becoming increasingly popular as people look for alternative treatments to traditional medication. The demand for sleeping aid devices is also increasing as people seek out solutions to physical challenges that may be affecting their sleep quality, such as snoring. These factors all contribute to the growth of the insomnia treatment market, which is expected to continue to expand in the coming years.

𝐒𝐩𝐞𝐚𝐤 𝐭𝐨 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐄𝐱𝐩𝐞𝐫𝐭 :https://www.alliedmarketresearch.com/connect-to-analyst/2373

The development of new non-pharmacological therapies and the launch of new insomnia treatment products, such as Eisai's DAYVIGO, are expected to drive the growth of the insomnia treatment market. However, it's important to note that long-term use of certain anti-insomnia drugs can have side effects that may impede the growth of the market. On the other hand, the development of advanced technology in healthcare and lifestyle sectors has increased the demand for insomnia treatment, with mobile phone software and health watches offering innovative solutions for tracking and improving sleep quality. These technological advancements have made it easier for people to monitor and manage their sleep patterns, which is expected to contribute to the growth of the insomnia treatment market. Overall, the market for insomnia treatments is expected to continue to expand as new therapies and products are developed and as technology continues to advance in the healthcare industry.

 𝐈𝐧𝐬𝐨𝐦𝐧𝐢𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

The insomnia treatment market by therapy type and region.

By Therapy Type:

The insomnia treatment market can be segmented by therapy type into non-pharmacological therapy and pharmacological therapy.

Non-pharmacological Therapy: This type of therapy involves the use of non-medical interventions to improve sleep quality. Non-pharmacological therapies include cognitive-behavioral therapy (CBT), relaxation therapy, sleep hygiene education, hypnotherapy, and light therapy. CBT is the most common non-pharmacological therapy used for insomnia treatment. It involves a structured program of behavioral and cognitive techniques to improve sleep quality. Non-pharmacological therapy is expected to witness significant growth during the forecast period, as more people seek alternative treatments to traditional medication.

Pharmacological Therapy: This type of therapy involves the use of drugs to treat insomnia. The pharmacological therapy includes sedative-hypnotics, which are drugs that depress the central nervous system and induce sleep. Benzodiazepines and non-benzodiazepine hypnotics are the most commonly used drugs for insomnia treatment. However, the long-term use of these drugs can lead to side effects such as addiction, cognitive impairment, and daytime drowsiness.

By Region:

The insomnia treatment market can be segmented by region into North America, Europe, Asia-Pacific, and LAMEA.

North America: This region is expected to dominate the insomnia treatment market during the forecast period. The high prevalence of insomnia, increasing demand for non-pharmacological therapy, and the presence of key players in the region are some of the factors driving the growth of the market in North America. The United States is the largest market for insomnia treatment in North America.

Europe: Europe is expected to witness significant growth during the forecast period, owing to the increasing prevalence of insomnia and the growing demand for non-pharmacological therapy. Germany and the United Kingdom are the largest markets for insomnia treatment in Europe.

Asia-Pacific: Asia-Pacific is expected to witness the fastest growth during the forecast period. The high prevalence of insomnia in the region, the growing demand for non-pharmacological therapy, and the increasing adoption of advanced technology in healthcare are some of the factors driving the growth of the market in Asia-Pacific. China and Japan are the largest markets for insomnia treatment in the region.

LAMEA: The LAMEA region is expected to witness moderate growth during the forecast period. The increasing prevalence of insomnia, rising awareness about the condition, and the growing demand for non-pharmacological therapy are some of the factors driving the growth of the market in the region. Brazil and South Africa are the largest markets for insomnia treatment in LAMEA.

𝐐𝐮𝐢𝐜𝐤𝐥𝐲 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐈𝐧𝐬𝐨𝐦𝐧𝐢𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 :https://www.alliedmarketresearch.com/checkout-final/369b209228836a0db596615095f24eba

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

𝐈𝐧𝐭𝐫𝐚𝐨𝐫𝐚𝐥 𝐒𝐜𝐚𝐧𝐧𝐞𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.alliedmarketresearch.com/intraoral-scanners-market

𝐏𝐧𝐞𝐮𝐦𝐨𝐧𝐢𝐚 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.alliedmarketresearch.com/pneumonia-testing-market

𝐔𝐥𝐜𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐂𝐨𝐥𝐢𝐭𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.alliedmarketresearch.com/ulcerative-colitis-market

𝐂𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐈𝐧𝐣𝐞𝐜𝐭𝐨𝐫 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.alliedmarketresearch.com/contrast-injector-systems-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.